Join ARMI BioFabUSA to hear from pioneering speakers in the field and to update your knowledge on stem cell derived beta cell therapy, both experimental and clinical, for the treatment of diabetes.
Dr. Tom Bollenbach will present on Tuesday, April 25 during the The Islet Product, Planning for Trials, and Manufacturing Session. Dr. Bollenbach will discuss “Scale – up manufacturing; how to do it or not so easy?”
The Advanced Regenerative Manufacturing Institute (ARMI) is a member-based, nonprofit organization whose mission is to advance the bioeconomy of the United States.
BioFabUSA, a program of ARMI, is a public-private partnership with more than 170 members, including companies, academic institutions and not-for profit organizations.
ARMI BioIndustries is the full-service development and manufacturing operation within the Advanced Regenerative Manufacturing Institute.
NextFab is the first foundry for American biotechnology. The mission of NextFab is to produce technological solutions that help the United States protect against and respond to health-security threats, enhance daily medical care and add to the U.S. bioeconomy.
BioFabUSA, a program of ARMI, is a public-private partnership with more than 170 members, including companies, academic institutions and not-for profit organizations.
